Videos for all the sessions are now posted.

Click on the links on this page.

The presentations for the following Summit speakers are available for download:

• Emerging Business Trends- Opportunities and Challenges for New Jersey’s Life Sciences Cluster
  • Michael Pazzani, VP, Research and Development, Rutgers University
  • Richard Evans, Managing Director, Sector and Sovereign
  • 
    

• Star Attraction: How Do We Attract (and keep) the Best and the Brightest?
  • Donald Sebastian, Provost (Interim) & Senior VP for Research & Development, New Jersey Institute of Technology
  • Brian A. Leuthner, President & CEO, Edge Therapeutics, Inc.
  • Joseph Mintzer. Executive Vice President & COO, Coriell Institute
  • Mahmud Hassan, Professor and Director, Pharmaceutical MBA Program, Rutgers Business School – Newark and New Brunswick

BioNJ, one of our Supporting Organizations, is holding their BioPartnering Conference. Please download the brochure for more information.

BioNJ BioPartnering 2010 Conference Brochure

Hi all,

We had a great event last Friday. The Summit went off without any major hitches. We had over 170 people in attendance and many stayed to the end.

Our panelists addressed issues of concern to the life sciences industry and several participants shared their satisfaction with the event.

We’re in the midst of conducting a post-event evaluation, so we can find out what worked or didn’t work.

I hope to have the conference slides posted in a day or so. Video should be available next week.

In the meantime, please call me with any questions or comments.

Drew Harris

Summit Chair,

President, NJABR

Paul Chew, Chief Science Officer and Chief Medical Officer for Sanofi-Aventis, is joining the Summit as a panelist. He will be participating in a panel discussion on "Emerging Business Trends – Opportunities and Challenges for New Jersey’s Life Sciences Cluster." Previously, Dr. Chew was President, U.S. Research & Development and Vice President, Therapeutic Department Head, Metabolism, Diabetes and Thrombosis at Sanofi-Aventis.

Background information about Sanofi-Aventis’ R&D activities have been posted.

I’m happy to announce that Harold J. Wirths, NJ Acting Commissioner of Labor and Workforce Development, has confirmed his attendance at the Summit and will be participating in the third panel, Workforce Development- How Can NJ’s Life Sciences Professionals Position themselves for the Future?

Also, Caren Franzini, CEO of the NJ Economic Development Authority, will be joining us as a participant in the afternoon case study.

Should be an exciting day.

Please tell us what you think about the state of New Jersey’s life sciences industry.

Your comments won’t show up until the moderator reviews them. Feel free to post links to your YouTube videos.

Introductory comments from Drew Harris, Chair of the NJ International Life Sciences Summit and President of the NJ Association for Biomedical Research.

New Jersey International Life Sciences Workforce Summit

April 23, 2010 – 8:30 a.m. – 4:00 p.m.

Woodrow Wilson School, Princeton University

Biotechnology and other life sciences companies in New Jersey are integral to New Jersey’s job growth and future economic health.  However, the effects of restructuring and mega-mergers among pharmaceutical companies have taken a toll on some industry functions. Today’s forum brings together experts from academia, business, and government to examine the life sciences industry in light of the changing industry models in the state. They will discuss how New Jersey can build on its current ranking as the eighth- largest biotechnology center in the nation in order to promote itself as an attractive place to site new businesses, develop innovative methods for attracting and retaining a talented workforce, and offer opportunities for worker development. Download the NJ International Life Sciences Workforce Summit brochure. To register follow this link.